Nadim Anwer, Pharma Analyst at GlobalData, comments, The semaglutide patent cliff in China represents a paradigm shift that will broaden access to life-changing GLP-1 therapies while creating a new competitive landscape dominated by local players
Once the needle is inserted, turn the vial and syringe upside down, making sure that the tip of the needle is submerged in the liquid
Even with sophisticated delivery systems, achieving oral bioavailability above 1-2% for a peptide drug was long considered an exceptional achievement
Patients can afford both their therapy and the needles required for safe administration without financial strain
These injections are commonly used to treat vitamin B12 deficiencies, which can result from dietary restrictions, malabsorption issues, or conditions like pernicious anaemia
Additionally, gastrointestinal side effects, such as nausea, vomiting, and diarrhea, are commonly associated with GLP-1 receptor agonists, especially during the initial phase of treatment